Status:
RECRUITING
Hemodynamic Effect of Nasal High-flow in Patients Suspected or Followed for a Precapillary Pulmonary Hypertension
Lead Sponsor:
ADIR Association
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, the investigators aim to describe the hemodynamic consequences of nasal high-flow measured during right heart catheterization and echocardiography. The research hypothesis is that nasal...
Eligibility Criteria
Inclusion
- \- patient addressed for right heart catheterization for pulmonary hypertension suspicion or follow-up.
Exclusion
- necessity of FiO2 \>21% during right heart catheterization
- intracardiac shunt
- grade 4 tricuspid insufficiency
- complete arrhythmia due to atrial fibrillation
- Pregnant or breastfeeding women or women of childbearing age without an effective method of contraception
- protected adult patient (tutorship or curatorship)
- patient deprived of liberty by court or administrative decision
- refusal of patient participation or consent
- patient for whom the measurement of pulmonary arterial pressures during right heart catheterization is impossible
- patient for whom, during the etiological assessment of pulmonary hypertension, the diagnosis of precapillary pulmonary hypertension cannot be confirmed and classified in groups 1, 3 or 4.
Key Trial Info
Start Date :
February 13 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 12 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06079151
Start Date
February 13 2024
End Date
February 12 2026
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ROUEN university hospital
Rouen, France, 76000